Education
About Us
Working with TipRanks
Follow Us
Novartis AG (DE:NOT)
XETRA:NOT
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 57.13B | $ 51.72B | $ 46.66B | $ 43.46B | $ 43.97B |
| Gross Profit | $ 42.86B | $ 38.90B | $ 34.19B | $ 31.88B | $ 32.24B |
| Operating Income | $ 17.80B | $ 14.54B | $ 9.77B | $ 7.95B | $ 10.06B |
| EBITDA | $ 23.96B | $ 20.71B | $ 18.25B | $ 14.68B | $ 30.91B |
| Net Income | $ 14.65B | $ 11.94B | $ 14.85B | $ 6.96B | $ 24.02B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 11.58B | $ 13.35B | $ 13.96B | $ 18.61B | $ 28.11B |
| Total Assets | $ 115.49B | $ 102.25B | $ 99.94B | $ 117.45B | $ 131.79B |
| Total Debt | $ 37.01B | $ 31.26B | $ 26.35B | $ 27.91B | $ 31.02B |
| Net Debt | $ 25.58B | $ 19.80B | $ 12.96B | $ 20.39B | $ 18.62B |
| Total Liabilities | $ 68.97B | $ 58.12B | $ 53.20B | $ 58.03B | $ 63.97B |
| Stockholders' Equity | $ 46.10B | $ 44.05B | $ 46.67B | $ 59.34B | $ 67.66B |
| Cash Flow | |||||
| Free Cash Flow | $ 18.43B | $ 13.80B | $ 11.71B | $ 11.56B | $ 12.10B |
| Operating Cash Flow | $ 20.05B | $ 17.62B | $ 14.46B | $ 14.24B | $ 15.07B |
| Investing Cash Flow | $ -5.11B | $ -7.51B | $ 5.60B | $ 1.47B | $ 4.21B |
| Financing Cash Flow | $ -15.57B | $ -11.74B | $ -14.28B | $ -20.56B | $ -16.26B |